ISRCTN49579665已完成不适用
Pharmacokinetics of 6-thioguanine
VU University Medical Centre (VUMC) (The Netherlands)0 个研究点目标入组 16 人开始时间: 2007年2月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Irritable Bowel Disease (IBD)
- •2. In need of immunosuppressants
- •3. Intolerant to azathioprine or methotrexate
排除标准
- •1. Concomitant use of drugs interfering with thiopurine metabolism
- •2. Pregnancy/lactation
研究者
相似试验
已完成
不适用
Pharmacokinetics of 6-thioguanine.Crohn's disease of ulcerative colitis (IBD).NL-OMON23696/A16
尚未招募
1 期
Rectal and blood concentrations of thioguanine given by suppository in inflammatory bowel diseaseinflammatory Bowel DiseaseOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12623001337662Douglas Pharmaceuticals15
已完成
2 期
Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)Hodgkin's DiseaseNCT00587873Memorial Sloan Kettering Cancer Center18
已完成
不适用
Supralimus-Core(TM) Pharmacokinetic(PK) StudyCTRI/2009/091/000426Sahajanand Medical Technologies Pvt Ltd20
进行中（未招募）
不适用
Pharmacokinetics and dose-ranging of tiotropium inhalation solution delivered from the Respimat inhaler in patients with Chronic Obstructive Pulmonary Disease (COPD)EUCTR2009-016251-21-DKBoehringer Ingelheim (UK) Ltd160